After Bribery Settlement, Eli Lilly Sees Shareholder Derivative Suit

Douglas Gillison

01 November 2013

Currently dealing with allegations in China, the company's board is being sued for its handling of a bribery matter it settled last year with the SEC.

Subscribe to Global Investigations Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.

Subscribe now

Already have access? Login below

Douglas Gillison

View full biography

Author

[email protected]

Unlock unlimited access to all Global Investigations Review content